Medication Adjustment for ADHD and Comorbid Conditions

Current Medication Assessment

The American Academy of Sleep Medicine indicates that methylphenidate (Concerta/Ritalin) is considered first-line therapy for ADHD in children due to its large effect sizes for reducing core ADHD symptoms 1
Guanfacine (Intuniv) is an alpha-2 adrenergic receptor agonist that can be used as monotherapy or as an adjunct to stimulants for ADHD, as stated by the Pharmacology and Therapeutics journal 1
The recent bedwetting incident may be related to medication side effects or comorbid conditions, according to The Journal of Urology 2, 3

The optimal dose of guanfacine for children with ADHD is 0.15mg/kg, as indicated by the Journal of Clinical Sleep Medicine 4
For an 8-year-old, this would suggest a target dose of 3.75-4.5mg, based on an average weight of approximately 25-30kg, according to the Journal of Clinical Sleep Medicine 4
Increase Intuniv gradually from 1mg to 3-4mg (based on weight) over 2-4 weeks, as recommended by Pharmacology and Therapeutics 1

Guanfacine has shown efficacy in treating both ADHD and ODD symptoms, with stronger evidence for efficacy in children who have previously been treated with methylphenidate, as stated by Pharmacology and Therapeutics 1
Higher doses of guanfacine (up to 0.15mg/kg) have demonstrated better response rates in clinical trials, according to the Journal of Clinical Sleep Medicine 4

The bedwetting episode requires further evaluation as it could be a separate clinical issue requiring specific management, as indicated by The Journal of Urology 2, 3
Assessment should include frequency of bedwetting, timing of medication administration relative to bedtime, evaluation of fluid intake patterns, and screening for constipation, which can contribute to bedwetting, according to The Journal of Urology 2

Schedule follow-up in 2-4 weeks to assess response to the adjusted Intuniv dose, as recommended by Praxis Medical Insights 5
Monitor for common side effects of guanfacine, including hypotension, as stated by Pharmacology and Therapeutics 1
Assess vital signs (blood pressure and pulse) at each follow-up visit, as recommended by Praxis Medical Insights 5
Use standardized ADHD rating scales to objectively measure symptom improvement, according to Praxis Medical Insights 5

Guanfacine's full therapeutic effect may take 2-4 weeks to develop, unlike the immediate effects of stimulants, as stated by Pharmacology and Therapeutics 1
If bedwetting persists or worsens, consider adjusting the timing of medication administration or further evaluation for primary enuresis, as indicated by The Journal of Urology 2, 3
Be aware that guanfacine should not be discontinued abruptly due to potential rebound hypertension, as warned by Pharmacology and Therapeutics 1